Kinnate Biopharma Inc (DELISTED) (KNTE:DL)

2.65 0.00 (0.00%) USD  |  NASDAQ  |  Apr 03, 16:00
More

Kinnate Biopharma Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for KNTE:DL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2021. Upgrade now.
Date Value
April 04, 2024 --
April 03, 2024 --
March 02, 2024 --
February 16, 2024 --
September 19, 2023 --
August 15, 2023 --
August 09, 2023 --
May 12, 2023 --
April 18, 2023 --
April 14, 2023 --
March 16, 2023 --
March 15, 2023 --
February 26, 2023 --
September 22, 2022 --
September 12, 2022 --
August 19, 2022 --
Date Value
August 17, 2022 --
July 28, 2022 --
May 13, 2022 --
March 29, 2022 --
March 28, 2022 --
February 08, 2022 --
November 11, 2021 --
September 27, 2021 --
September 22, 2021 --
August 18, 2021 --
August 17, 2021 --
August 16, 2021 --
May 04, 2021 --
April 14, 2021 --
March 30, 2021 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

--
Minimum
Mar 30 2021
--
Maximum
Mar 30 2021
--
Average
--
Median
Mar 30 2021

Revenue Estimates for Next Fiscal Year Benchmarks

XOMA Corp Upgrade
Societal CDMO Inc (DELISTED) Upgrade
NGM Biopharmaceuticals Inc (DELISTED) Upgrade
Avrobio Inc Upgrade
Landos Biopharma Inc (DELISTED) Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade